Search Results - "Lahti, Robert A"

Refine Results
  1. 1
  2. 2
  3. 3

    D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects by Lahti, R A, Roberts, R C, Conley, R R, Cochrane, E V, Mutin, A, Tamminga, C A

    Published in Neuroreport (12-08-1996)
    “…The density of the presumed dopamine D4 receptor ([3H]YM-09151-2 minus [3H]raclopride), as well as the densities of the two ligands themselves were compared in…”
    Get more information
    Journal Article
  4. 4

    Regional expression of RGS4 mRNA in human brain by Erdely, Holly A., Lahti, Robert A., Lopez, Mary B., Myers, Carol S., Roberts, Rosalinda C., Tamminga, Carol A., Vogel, Michael W.

    Published in The European journal of neuroscience (01-06-2004)
    “…Regulators of G‐protein signalling (RGS) proteins are a recently discovered class of proteins that modulate G‐protein activity. More than 20 RGS proteins have…”
    Get full text
    Journal Article
  5. 5

    D2-family receptor distribution in human postmortem tissue: an autoradiographic study by Lahti, R A, Roberts, R C, Tamminga, C A

    Published in Neuroreport (15-12-1995)
    “…The distribution throughout the normal human brain of the dopamine D2-family of receptors were investigated autoradiographically. Three ligands were used,…”
    Get more information
    Journal Article
  6. 6

    Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications by Lahti, R A, Evans, D L, Stratman, N C, Figur, L M

    Published in European journal of pharmacology (04-06-1993)
    “…The dopamine D4 receptor, which is considered a close variant of the dopamine D2 receptor, has recently been cloned. Receptor binding studies demonstrated that…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands by Chidester, Connie G, Lin, Chiu Hong, Lahti, Robert A, Haadsma-Svensson, Susanne R, Smith, Martin W

    Published in Journal of medicinal chemistry (14-05-1993)
    “…Conformational and molecular mechanics studies of a new series of tricyclic ligands with affinity for either the dopamine D2 receptor or the 5-HT1A receptor,…”
    Get full text
    Journal Article
  9. 9

    Synthesis and pharmacology of novel anxiolytic agents derived from 2-[(dialkylamino)methyl-4H-triazol-4-yl]benzophenones and related heterocyclic benzophenones by Gall, Martin, Hester, J. B, Rudzik, A. D, Lahti, Robert A

    Published in Journal of medicinal chemistry (01-08-1976)
    “…A series of novel [(dialkylamino)methyl-4H-1,2,4-triazol-4-yl]benzophenones and related compounds has been prepared via total synthesis from substituted…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor by Cheney, B. Vernon, Szmuszkovicz, Jacob, Lahti, Robert A, Zichi, Dominic A

    Published in Journal of medicinal chemistry (01-12-1985)
    “…In this paper, we describe the synthesis of a series of trans-N-[2-(methylamino)cyclohexyl]benzamides possessing morphine-like pharmacological properties. The…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Novel indolodioxanes with antihypertensive effects: potent ligands for the 5-HT1A receptor by Ennis, Michael D, Baze, Mark E, Smith, Martin W, Lawson, Charles F, McCall, Robert B, Lahti, Robert A, Piercey, Montford F

    Published in Journal of medicinal chemistry (01-08-1992)
    “…The synthesis and biological evaluation of a new family of tricyclic indolodioxanes is described. These compounds all contain the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Conversion of N-alkylaminobenzophenones to benzodiazepines in vivo by Lahti, Robert A, Gall, Martin

    Published in Journal of medicinal chemistry (01-08-1976)
    “…The results of this study suggest that 5-chloro-2-[3-methyl-5-(dimethylamino)methyltriazol-4-yl]benzophenone can undergo N-dealkylation and ring closure in…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Images in neuroscience: Clinical genetics, V by Lahti, Robert A, Lahti, Adrienne C

    Published in The American journal of psychiatry (01-11-1997)
    “…The distinctive functional characteristic that the D4,7 variant of the D4 dopamine receptor brings (excitability/impulsiveness) to the human brain is…”
    Get full text
    Journal Article
  19. 19

    [3H]U-69593 a highly selective ligand for the opioid kappa receptor by Lahti, R A, Mickelson, M M, McCall, J M, Von Voigtlander, P F

    Published in European journal of pharmacology (26-02-1985)
    “…The selective kappa agonist U-50488 was recently discovered and characterized. In this study, the receptor binding properties of [3H]U-69593, an analog of…”
    Get more information
    Journal Article
  20. 20

    Effect Of amphetamine, α-Methyl-P-tyrosine (α-MPT) and antipsychotic agents on dopamine D 2-type receptor occupancy in rats by Lahti, Robert A., Tamminga, Carol A.

    “…1. 1. EEDQ inactivates unoccupied receptors vivo in brain tissue and is useful in determining which receptors are occupied by a drug treatment. 2. 2. α-MPT,…”
    Get full text
    Journal Article